Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 37Liver Neoplasms 18Neoplasm Metastasis 17Colorectal Neoplasms 13Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 8Colonic Neoplasms 8Breast Neoplasms 8Barrett Esophagus 7Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 5Thyroid Nodule 4Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Biliary Tract Neoplasms 3Agnosia 3Thyroid Diseases 2Prostatic Neoplasms 2Leiomyoma 2Hyperaldosteronism 2Cancer Pain 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 4Uterine Artery Embolization 4linzagolix 2ulipristal acetate 1ulipristal 1pycnogenols 1Tranexamic Acid 1Radiofrequency Ablation 1Progesterone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Ibuprofen 1Hysterectomy 1Endomet 1Electrocoagulation 1Cryosurgery 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Menorrhagia × Radiofrequency Ablation × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡